In addition to clinically and widely used tumor markers, such as carcinoembryonic antigen[4] and cancer antigen 15–3[5], other clinical laboratory indicators are urgently needed to assist in differential diagnosis and predict prognosis. The gene discussed is CEACAM5; the disease is neoplasm.